Distribution · 19 May 2026 · 6 min read

IMO vs FMO vs BGA: what's the difference?

Gerard Cavaleri Virtual Closer

Four acronyms, heavily overlapping, used inconsistently by the organisations themselves. Here is what each one actually means, where the lines genuinely fall, and — the part that matters — how to tell which one you are talking to.

The short version. All four are intermediaries between insurance carriers and the agents who sell their products. They recruit agents, hold carrier contracts, distribute commission, and provide some mix of training, leads and support. The differences are about scale, which products and what authority the carrier delegates — not about four cleanly separated categories. In practice the terms are used loosely, and many organisations describe themselves with more than one.

IMO and FMO are used interchangeably in practice and no regulator enforces a distinction. MGA is the one materially different item — delegated underwriting authority is a legal relationship, not a marketing label.

Where the lines actually fall

BGA — Brokerage General Agency. The most specific term of the four. A BGA is traditionally life-insurance focused, works with independent brokers rather than captive agents, and adds real case-management value: underwriting support, shopping a difficult case across carriers, and handling the paperwork on complex or impaired-risk business. If someone calls themselves a BGA, they usually mean "we help you place hard cases."

FMO — Field Marketing Organisation. Most associated with Medicare and senior products. An FMO typically holds top-level contracts with carriers and focuses on recruiting and supporting a large field force. In Medicare specifically, FMOs handle certification, compliance and the annual enrolment cycle, which is its own operational discipline.

IMO — Independent Marketing Organisation. The broadest and least standardised term. IMOs recruit independent agents across life, annuity and health, and compete largely on contract level, tools and support. Many organisations use IMO and FMO interchangeably, and there is no regulator enforcing a distinction.

MGA — Managing General Agent. The one genuinely different thing on the list. An MGA has been delegated actual underwriting authority by a carrier — it can bind coverage, and sometimes handle claims. That is a legal relationship with the carrier, not a marketing arrangement. If a distributor is an MGA, that is a substantive fact about what they can do, not a branding choice.

How they get paid, and why that matters to you

All of them are compensated out of the commission the carrier pays on business their downline writes. The agent contracts at a level; the upline holds a higher level; the difference — the override — is the intermediary's revenue. This is why "what level am I contracted at" is the single most consequential question in the conversation.

A higher contract level is not automatically better. Organisations offering the highest levels are often offering the least support, because the override is what funds leads, training, case management and technology. The honest framing is a trade: you are choosing how much of your commission to exchange for infrastructure.

What to actually ask

The acronym tells you very little. These questions tell you a lot:

• What level am I contracted at, and what does the level above me get? A straight answer here is itself a signal.
• Are my contracts assignable, and what is the release policy? This determines whether you can leave without abandoning your book. It is the question most new agents forget to ask and most regret not asking.
• How long does contracting actually take? Carrier timelines are unpredictable — days to weeks — and how an upline manages that gap says a lot about their operation.
• What do I get for the override? Leads, training, case support, technology, or a logo on a website. All four are legitimate answers; you should know which one it is.
• Who owns the client relationship if I leave? Get it in writing.

Does the distinction matter?

Less than the industry's use of the terms suggests. For an independent agent choosing an upline, the meaningful variables are contract level, release policy, product access, and what support actually arrives — none of which is determined by whether the organisation calls itself an IMO or an FMO. The one exception is MGA: delegated underwriting authority is a real difference with real consequences.

The question that matters most, and almost nobody asks

What is your release policy? Contracting with an intermediary is not like taking a job. If the relationship stops working, you generally cannot simply move your carrier contracts elsewhere — you need a release, and whether you get one, how long it takes, and whether it applies to all carriers or some, is set by the organisation you are leaving.

Some release on request. Some enforce a waiting period, commonly six months of no production, before you may recontract with the same carrier through anyone else. Some negotiate case by case. None of this is unusual or improper — but it is the term with the largest effect on your options in two years, and it is the one least likely to be raised in a recruiting conversation.

Ask early, ask for it in writing, and ask specifically whether it differs by carrier. A generous contract level attached to a restrictive release is a worse deal than it looks, and you will not find that out until you want to leave. Contracting friction is a known pain point across this whole distribution layer (Coverager, producer-to-carrier contracting challenges).

Common questions

Virtual Closer models hierarchy levels and override spread directly — comp by carrier, product and age band at each level, with the spread shown per sale. If you run a downline, that is the part most CRMs cannot express.